Measurements of BMD at LS (Figure 1A) and TH (Figure 1B) in patients with ER+ BC revealed normal BMD in more premenopausal patients compared with postmenopausal patients (>80 vs ∼60%). This evidence concerns the gene ESR1 and breast cancer.